Yanqiu Zhao, MS
Henan Tumor Hospital
2
2
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Ningbo Liu, Doctor
Tianjin Medical University Cancer Institute and Hospital
Shared therapeutic areas:
Dong Wang, PH.D
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Shared therapeutic areas:
Shun Lu, Professor
Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiaotong University, P. R. China
Shared therapeutic areas:
Shuhang wang, PhD
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Shared therapeutic areas:
Zhijie Wang, MD, PhD
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Shared therapeutic areas:
Dingzhi Huang, M.D
Tianjin Medical University Cancer Institute and Hospital
Shared therapeutic areas:
Martin Reck, Prof. Dr.
LungenClinic Grosshansdorf
Shared therapeutic areas:
Dingzhi Huang, Doctor
Tianjin Medical University Cancer Institute and Hospital
Shared therapeutic areas:
Chunxia Su, Doctor
Shanghai Pulmonary Hospital, Shanghai, China
Shared therapeutic areas:
Richard Greil, MD
AGMT gemeinnützige GmbH
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Utidelone in Third-line and Above Treatment of Small Cell Lung Cancer
Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer
All 2 trials loaded